Literature DB >> 29366622

Resection of the largest reported hepatic small vessel neoplasm.

Sarah Walcott-Sapp1, Ephraim Tang2, Sanjay Kakar3, Jian Shen4, Paul Hansen5.   

Abstract

Hepatic small vessel neoplasm (HSVN) is a recently described vascular neoplasm of the adult liver. The neoplastic cells are positive for markers of vascular lineage (CD31, CD34, FLI-1). The distinctive morphology and infiltrative borders separate HSVN from benign vascular tumors such as cavernous hemangioma, while lack of atypical morphologic features, low to absent mitotic activity and low proliferation index distinguish it from malignant vascular tumors such as epithelioid hemangioendothelioma and angiosarcoma. Due to its infiltrative nature and lack of adequate follow-up information, the benign versus low-grade nature of this tumor is currently uncertain. We present a patient with resected HSVN involving all but the right posterior section of the liver, making this case the largest reported in the current literature.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiosarcoma; Hemangioma; Hepatic small vessel neoplasm; Hepatic vascular neoplasm; Liver

Mesh:

Substances:

Year:  2018        PMID: 29366622     DOI: 10.1016/j.humpath.2018.01.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

Review 1.  Vascular tumours of the liver: a particular story.

Authors:  Jan Lerut; Samuele Iesari
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-14

Review 2.  Hepatic small vessel neoplasm - A systematic review.

Authors:  Ian Y Goh; Patricia Mulholland; Anna Sokolova; Cheng Liu; Mehan Siriwardhane
Journal:  Ann Med Surg (Lond)       Date:  2021-11-01

3.  Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.

Authors:  Fei Chen; Qilai Long; Da Fu; Dexiang Zhu; Yan Ji; Liu Han; Boyi Zhang; Qixia Xu; Bingjie Liu; Yan Li; Shanshan Wu; Chen Yang; Min Qian; Jianmin Xu; Suling Liu; Liu Cao; Y Eugene Chin; Eric W-F Lam; Jean-Philippe Coppé; Yu Sun
Journal:  Nat Commun       Date:  2018-10-17       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.